mRNA: Therapeutics and Global Markets
Report Scope:
This report focuses on the mRNA therapeutics market. This reports include the types of mRNA and their application in therapy. Also, the report focuses on the patent analysis and clinical trial analysis of mRNA. The report also portrays the trends and dynamics affecting the market during the study period. The study covers market projections through 2028 and profiles major market players.
By geography, the market is segregated into North America, Europe, Asia-Pacific and the Rest of the World (RoW). The market is estimated through 2028.
BCC Research also summarizes the main industry acquisitions and strategic alliances from January 2020 through December 2022 and identifies the trends in this activity.
Report Includes:
37 data tables and 27 additional tables
An overview of the global market related to mRNA therapeutics
In-depth analysis of global market trends, featuring historical revenue data for 2021 and 2022, estimated figures for 2023, forecasts for 2028, and projections of compound annual growth rates (CAGRs) through 2028
Evaluation of the current market and revenue growth prospects specific to mRNA therapeutics, accompanied by a market share analysis by therapeutic type and geographical region
Coverage of the pandemic threats, therapeutic developments, and new technologies in the market
Discussion of the advantages of mRNA over proteinand DNA-based delivery systems, demographic and economic trends, and outlook for the mRNA therapeutics market
Information on prophylactic vaccines, vaccine discovery and development, and R&D activities
Analysis of the various therapeutics as well as promising vaccines intended for the prevention and treatment of chronic and infectious diseases
Assessment of regulatory structure, pricing and reimbursement scenarios, the pipeline for new molecules and therapeutics
Market share analysis of the key companies and mergers & acquisitions, joint ventures, collaborations, and partnerships
Profiles of leading market participants
Companies Mentioned
BioNTech SE
MERCK KGAA
Moderna Inc.
NUTCRACKER THERAPEUTICS
STRAND THERAPEUTICS
- Chapter 1 Introduction
- Study Goals and Objectives
- Reasons for Doing This Study
- Scope of Report
- What's New in This Update?
- Methodology
- Information Sources
- Geographic Breakdown
- Segmentation Breakdown
- Chapter 2 Summary and Highlights
- Market Outlook
- Market Summary
- Chapter 3 Market Overview
- Evolution of RNA Therapeutics
- History of RNA Therapeutics
- Development of RNA Therapeutics and Types
- DNA Therapeutics vs. RNA Therapeutics
- Clinical Need for RNA Therapeutics
- Increasing Disease Population and Economic Burden
- Limitations of Traditional Therapeutics
- Therapeutic Limitations of Biologics
- Poor Management of Chronic Diseases
- Limited Treatment for Rare Diseases
- RNA Therapeutics
- Antisense Oligonucleotide (ASO) as Therapeutics
- Small Interfering RNA (siRNA) as Therapeutics
- miRNA as Therapeutics
- Aptamers as Therapeutics
- mRNA as Therapeutics
- Manufacturing RNA-Based Biopharmaceuticals
- Chromatographic Purification Steps
- Delivery of RNA Therapeutics
- Polymer Conjugation/Chemical Modification
- Encapsulation
- Lipid-Based Nanoparticles
- Polymer Nanomaterials
- Silica Nanoparticles
- Carbon and Gold Nanomaterials
- GalNAc
- Institution and Hospital-Based RNA Therapeutics
- Regulatory Influence on the Market for RNA Therapeutics
- Impact of COVID-19
- Chapter 4 Market Dynamics
- Market Dynamics
- Drivers
- Restraints
- Opportunities
- Chapter 5 Target Disease and Disorders
- Overview of Common Diseases and Disorders for mRNA Therapeutics
- Cancer
- Infectious Diseases
- Cardiovascular Disease
- Lifestyle Disorders
- Respiratory Disorders
- Musculoskeletal Disorders
- Gastrointestinal Disorders
- Urology Disorders
- Nephrology Disorders
- Immune Disorders
- Neurological Disorders
- Rare Diseases
- Other Disorders
- Tobacco Smoking and Associated Diseases
- Infectious Diseases: COVID-19 Pandemic and mRNA Therapeutics
- Chronic Diseases: Expanding Horizon for mRNA Therapeutics
- Unmet Needs of Rare Diseases: mRNA Therapeutics
- Aging, Gender and Onset of Diseases
- Global Demographics
- U.S. Demographics
- European Demographics
- Japanese Demographics
- Chapter 6 Pipeline and Clinical Trial Analysis
- mRNA Vaccines
- mRNA Therapeutics
- Clinical Trial Analysis
- Chapter 7 Market Breakdown by Product
- Mechanism of Action of mRNA COVID Vaccines
- Three Most-Advanced mRNA Vaccines
- Chapter 8 Market Breakdown by Region
- North America
- Canada
- Europe
- Asia-Pacific
- Japan
- South Korea
- China
- India
- Australia
- RoW
- Chapter 9 Emerging Technologies and Developments
- Overview
- Nanoparticles
- Modified mRNA
- Automated mRNA Synthesis Kits
- Bio Platforms
- Chapter 10 Patent Analysis
- Patent Analysis
- mRNA Publication
- Chapter 11 Outlook for Mergers & Acquisitions, and Venture Funding
- Chapter 12 Competitive Intelligence
- Chapter 13 Company Profiles
- ARCTUR U.S. THERAPEUTICS INC.
- BIONTECH SE
- CUREVAC N.V.
- GENNOVA BIOPHARMACEUTICALS LTD.
- MERCK KGAA
- MODERNA INC.
- NUTCRACKER THERAPEUTICS
- OMEGA THERAPEUTICS INC.
- STRAND THERAPEUTICS
- VAXESS TECHNOLOGIES INC.
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook